Organization and Business - (Details)										3 Months Ended
	May 09, 2024 USD ($)	Mar. 31, 2024 USD ($) $ / shares shares	Mar. 18, 2024 USD ($) shares	Mar. 15, 2024 USD ($) escrow_account	Nov. 16, 2023 USD ($)	Sep. 30, 2023 USD ($)	Sep. 18, 2023 USD ($)	Sep. 15, 2023 USD ($)	May 11, 2023 USD ($)	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($) shares	Jun. 03, 2024 USD ($)	Feb. 09, 2024 $ / shares	Dec. 31, 2023 USD ($) $ / shares shares	Nov. 28, 2023 $ / shares shares	Jun. 16, 2023 USD ($)	Jun. 09, 2023 USD ($)	Feb. 26, 2023	Dec. 31, 2022 shares	Jun. 15, 2021	Jun. 09, 2021	Oct. 30, 2020
Schedule of Equity Method Investments [Line Items]
Exercise price of warrants (in dollars per share) | $ / shares															$ 115.00
Common stock outstanding (in shares) | shares		18,811,398												18,671,142
Preferred stock, outstanding (in shares) | shares		0												0
Purchase agreement cash consideration amount				$ 180,000,000	$ 180,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.1000											$ 0.0001	$ 0.1000
Number of escrow accounts | escrow_account				3
Purchase agreement, adjustment escrow amount				$ 3,000,000
Purchase agreement, tax escrow amount				27,000,000
Notes escrow amount		$ 139,000,000		$ 139,000,000
Aggregate carrying value		172,227,000												$ 172,227,000
Gain (loss) on deconsolidation of subsidiary						$ 59,100,000
Fair value of holdings and subsidiaries at deconsolidation						75,600,000
Carrying value at deconsolidation						$ 16,500,000
Cash and cash equivalents		955,000									$ 13,333,000			2,548,000
Restricted cash		169,388,000									0			0
Accumulated deficit		598,627,000												624,048,000
Glocal
Schedule of Equity Method Investments [Line Items]
Step acquisition, ownership percentage after transaction																						100.00%
Innovations Group | Disposal Group, Disposed of by Sale, Not Discontinued Operations
Schedule of Equity Method Investments [Line Items]
Consideration									$ 56,000,000
Total loss on disposal group held for sale										$ 1,400,000
Proceeds from sale of business, net of expenses									$ 54,900,000
Innovations Group | Disposal Group, Held-for-sale, Not Discontinued Operations
Schedule of Equity Method Investments [Line Items]
Total loss on disposal group held for sale											$ 500,000
Innovations Group
Schedule of Equity Method Investments [Line Items]
Noncontrolling interest, ownership percentage by parent									100.00%									100.00%
Glocal
Schedule of Equity Method Investments [Line Items]
Common stock outstanding (in shares) | shares			7,503,016
Noncontrolling interest, ownership percentage by parent			94.81%
Preferred stock, outstanding (in shares) | shares			24,867
2026 Notes | Convertible notes
Schedule of Equity Method Investments [Line Items]
Debt instrument, interest rate																				6.25%	6.25%
Percentage of noteholders					0.88
Aggregate carrying value		115,000,000												115,000,000
2025 Notes | Convertible notes
Schedule of Equity Method Investments [Line Items]
Percentage of noteholders					0.69
Premium percentage													0.0500
Purchase agreement, notes escrow fund estimated balance																	$ 10,300,000
Aggregate carrying value		$ 57,227,000												$ 57,227,000		$ 57,200,000
2025 Notes | Convertible notes | Subsequent Event
Schedule of Equity Method Investments [Line Items]
Purchase agreement, notes escrow fund estimated balance												$ 19,700,000
Aggregate carrying value												37,300,000
Unamortized debt issuance costs												$ 200,000
Needham V. Uphealth Holdings
Schedule of Equity Method Investments [Line Items]
Fees awarded excluding interest							$ 31,300,000	$ 31,300,000
Settlement interest							6,500,000
Amount awarded to other party							$ 37,800,000
Annual settlement interest, percent							9.00%
Needham V. Uphealth Holdings | Subsequent Event
Schedule of Equity Method Investments [Line Items]
Amount awarded to other party	$ 37,800,000
Loss contingency accrual	$ 8,000,000
Glocal Vs. Uphealth
Schedule of Equity Method Investments [Line Items]
Amount awarded from other party			$ 80,700,000
Glocal Vs. Uphealth | Sabahat Azim
Schedule of Equity Method Investments [Line Items]
Amount awarded from other party			10,140,625
Additional damages from other party			27,740,625
Reimbursement of legal fees			4,488,562
Glocal Vs. Uphealth | Richa Azim
Schedule of Equity Method Investments [Line Items]
Amount awarded from other party			10,140,625
Additional damages from other party			27,740,625
Reimbursement of legal fees			4,488,562
Glocal Vs. Uphealth | Chowdhury
Schedule of Equity Method Investments [Line Items]
Amount awarded from other party			1,382,812.5
Additional damages from other party			3,782,812.5
Reimbursement of legal fees			4,488,562
Glocal Vs. Uphealth | Damodaran
Schedule of Equity Method Investments [Line Items]
Amount awarded from other party			6,650,669.64
Additional damages from other party			18,193,526.79
Reimbursement of legal fees			4,488,562
Glocal Vs. Uphealth | Kimberlite
Schedule of Equity Method Investments [Line Items]
Amount awarded from other party			1,185,267.86
Additional damages from other party			3,242,410.71
Reimbursement of legal fees			$ 4,488,562
Glocal Vs. Uphealth | Sabahat Azim, Richa Azim And Chowdhury
Schedule of Equity Method Investments [Line Items]
Annual settlement interest, percent			9.00%
Proceeds from reimbursement of emergency arbitration fees			$ 868,440
Common Stock
Schedule of Equity Method Investments [Line Items]
Number of shares called by each warrant (in shares) | shares															1
Common stock outstanding (in shares) | shares		18,811,000									16,784,000			18,671,000					15,054,000
Common Stock | Glocal
Schedule of Equity Method Investments [Line Items]
Noncontrolling interest, ownership percentage by parent			95.29%
Preferred Stock | Glocal
Schedule of Equity Method Investments [Line Items]
Noncontrolling interest, ownership percentage by parent			37.52%